BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33090721)

  • 1. Identification of a 9-gene prognostic signature for breast cancer.
    Tian Z; Tang J; Liao X; Yang Q; Wu Y; Wu G
    Cancer Med; 2020 Dec; 9(24):9471-9484. PubMed ID: 33090721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immune-related prognostic signature for predicting breast cancer recurrence.
    Tian Z; Tang J; Liao X; Yang Q; Wu Y; Wu G
    Cancer Med; 2020 Oct; 9(20):7672-7685. PubMed ID: 32841536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer.
    Wu Q; Zheng S; Lin N; Xie X
    BMC Med Genomics; 2023 Apr; 16(1):87. PubMed ID: 37098532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of prognostic signature and nomogram for patients with breast cancer.
    Su J; Miao LF; Ye XH; Cui MS; He XF
    Medicine (Baltimore); 2019 Mar; 98(11):e14617. PubMed ID: 30882627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
    Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
    Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel metabolic gene signature-based nomogram to predict overall survival in breast cancer.
    Sun X; Zhou ZR; Fang Y; Ding S; Lu S; Wang Z; Wang H; Chen X; Shen K
    Ann Transl Med; 2021 Mar; 9(5):367. PubMed ID: 33842588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
    Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a Nomogram Based on a Hypoxia-Related lncRNA Signature to Improve the Prediction of Gastric Cancer Prognosis.
    Chen Q; Hu L; Chen K
    Front Genet; 2020; 11():570325. PubMed ID: 33193668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma.
    Zhang D; Duan Y; Cun J; Yang Q
    Front Genet; 2019; 10():278. PubMed ID: 30984247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constructing a novel prognostic signature of tumor driver genes for breast cancer.
    Zhou L; Yi Y; Liu C; Chen Z
    Am J Transl Res; 2022; 14(7):4515-4531. PubMed ID: 35958490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
    Wu M; Yuan H; Li X; Liao Q; Liu Z
    Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
    [No Abstract]   [Full Text] [Related]  

  • 13. Preoperative Breast Immune Prognostic Index as Prognostic Factor Predicts the Clinical Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Chen L; Kong X; Huang S; Su Z; Zhu M; Fang Y; Zhang L; Li X; Wang J
    Front Immunol; 2022; 13():831848. PubMed ID: 35320931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis.
    Yang Y; Li Z; Zhong Q; Zhao L; Wang Y; Chi H
    Gland Surg; 2022 May; 11(5):892-912. PubMed ID: 35694087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 15-Gene Signature and Prognostic Nomogram for Predicting Overall Survival in Non-Distant Metastatic Oral Tongue Squamous Cell Carcinoma.
    Liu M; Tong L; Liang B; Song X; Xie L; Peng H; Huang D
    Front Oncol; 2021; 11():587548. PubMed ID: 33767977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer.
    Jia X; Chen B; Li Z; Huang S; Chen S; Zhou R; Feng W; Zhu H; Zhu X
    Front Oncol; 2021; 11():799223. PubMed ID: 35096599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A seven-nuclear receptor-based prognostic signature in breast cancer.
    Wu F; Chen W; Kang X; Jin L; Bai J; Zhang H; Zhang X
    Clin Transl Oncol; 2021 Jul; 23(7):1292-1303. PubMed ID: 33210236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma.
    Zeng F; Su J; Peng C; Liao M; Zhao S; Guo Y; Chen X; Deng G
    Front Oncol; 2020; 10():1710. PubMed ID: 33014847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancer.
    Ding S; Sun X; Zhu L; Li Y; Chen W; Shen K
    Int Immunopharmacol; 2021 Nov; 100():108122. PubMed ID: 34536743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.